Literature DB >> 11861079

Subtractive immunization: a tool for the generation of discriminatory antibodies to proteins of similar sequence.

Heidi Major Sleister1, A Gururaj Rao.   

Abstract

Antibodies specific for a protein of interest are invaluable tools for monitoring the protein's structure, location and activity. Due to the tendency of an immune system to mount a response toward the abundant, immunodominant epitopes in a protein mixture, difficulties are inherent in the isolation of antibodies specific for proteins that are rare or poorly immunogenic. Likewise, isolation of antibodies specific for a protein with significant sequence similarity to other proteins, such as those derived from protein engineering, may be challenging. Subtractive immunization is a technique proven to facilitate efforts to produce monoclonal antibodies specific for antigens that are present in low abundance in a protein mixture, poorly immunogenic and/or similar in sequence or structure to other proteins. This protocol provides a detailed, stepwise procedure for the isolation of antibodies specific for a protein with sequence similarity to other proteins. As an example, we describe methods established to isolate antibodies specific to a methionine-enriched variant of soybean vegetative storage protein beta (VSPbeta-Met) that shares 91.8% amino acid sequence identity to the wild-type protein (VSPbeta-WT). These methods include cyclophosphamide-induced immunosuppression of mice for the wild-type protein followed by immunization with VSPbeta-Met. As a result of this procedure, mouse polyclonal antibodies that exhibited 10-fold greater reactivity with VSPbeta-Met than VSPbeta-WT in an ELISA were generated. It is anticipated that this strategy will have utility for generating antibodies specific to protein variants derived from protein engineering.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861079     DOI: 10.1016/s0022-1759(01)00567-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Increased abundance of opioid receptor heteromers after chronic morphine administration.

Authors:  Achla Gupta; Jan Mulder; Ivone Gomes; Raphael Rozenfeld; Ittai Bushlin; Edmund Ong; Maribel Lim; Emeline Maillet; Mats Junek; Catherine M Cahill; Tibor Harkany; Lakshmi A Devi
Journal:  Sci Signal       Date:  2010-07-20       Impact factor: 8.192

Review 2.  In vivo opioid receptor heteromerization: where do we stand?

Authors:  D Massotte
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.

Authors:  Raphael Rozenfeld; Achla Gupta; Khatuna Gagnidze; Maribel P Lim; Ivone Gomes; Dinah Lee-Ramos; Natalia Nieto; Lakshmi A Devi
Journal:  EMBO J       Date:  2011-05-03       Impact factor: 11.598

4.  G-protein-coupled heteromers: regulation in disease.

Authors:  Ivone Gomes; Achla Gupta; Lakshmi A Devi
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

5.  Immune-tolerizing procedure for preparation of monoclonal antibodies against glycoprotein E of Pseudorabies virus.

Authors:  Shun Lu; Min Xiang; Hanbing Dan; Bin Wu; Qishuang Gao; Haijun Huang; Qigai He; Huanchun Chen
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-02

6.  A rapid subtractive immunization method to prepare discriminatory monoclonal antibodies for food E. coli O157:H7 contamination.

Authors:  Min Jin; Jing Lang; Zhi-Qiang Shen; Zhao-Li Chen; Zhi-Gang Qiu; Xin-Wei Wang; Jun-Wen Li
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

Review 7.  Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.

Authors:  Ivone Gomes; Achla Gupta; Ittai Bushlin; Lakshmi A Devi
Journal:  Front Pharmacol       Date:  2014-12-03       Impact factor: 5.810

Review 8.  Enhanced immunization techniques to obtain highly specific monoclonal antibodies.

Authors:  Rodrigo de Almeida; Cecília Naomi Nakamura; Marina de Lima Fontes; Elenice Deffune; Sérgio Luis Felisbino; Ramon Kaneno; Wagner José Fávaro; Athanase Billis; Marcel Otavio Cerri; Ana Marisa Fusco-Almeida; Maria José Mendes Giannini; Andrei Moroz
Journal:  MAbs       Date:  2017-10-06       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.